BeStock  
Stocks › Biotechnology › FDMT

4D Molecular Therapeutics FDMT

US equityMarket cap rank #3512Biotechnology
$10.23 −$0.49 (-4.57%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $10.23 0.00%
Open$10.36
Prev close$10.72
Day range$10.11 – $10.94
Volume691.0K
Market cap$576.76M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-4.5x
CheapRich

Around its usual level · 42nd percentile, 5-year average -4.3x

Price / book2.0x
CheapRich

Above its usual level · 67th percentile, 5-year average 1.7x

#3121 of 5328 stocks by PB (1 = cheapest)

Price / sales7.2x
CheapRich

Near the bottom of its 5-year range · 8th percentile, 5-year average 2,484.2x

#4284 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-14x-9x-5x0xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$21.16
Price vs. fair value-51.7%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 2.04 – 1.71 67% (pricier than usual) #3121 of 5328 (1 = cheapest)
PE -4.53 -2.22 -4.35 42% (cheaper than usual) –
PS 7.18 54.45 2,484.22 8% (cheaper than usual) #4284 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on FDMT.

Sign in to join the discussion.

Scroll to Top